About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 5945 record(s)
Req # A-2020-000054
Adverse Reaction Report (AER) for ULORIC. Report number: 000735448.Organization: Health Canada
May 2020
Req # A-2020-000063
Adverse Reaction Report (AER). Report numbers: E2B_02928614, E2B_02934756, E2B_02951574.Organization: Health Canada
May 2020
Req # A-2020-000084
Adverse Reaction Report (AER). Report number: 000705709.Organization: Health Canada
May 2020
Req # A-2020-000117
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 19-123505-887, Priorities to Address Aging Information Technology.Organization: Health Canada
May 2020
Req # A-2020-000120
Adverse Reaction Report (AER). Report numbers: 000737101, 000737106.Organization: Health Canada
May 2020
Req # A-2020-000129
Adverse Reaction Report (AER). Report numbers: E2B_02885721, E2B_02891230, E2B_02894317, E2B_02898124, E2B_02898148.Organization: Health Canada
May 2020
Req # A-2020-000205
Adverse Reaction Report (AER) for Cabazitaxel for Injection. Report number: 02487497. ADR for Daptomycin for Injection (350 mg/vial). Report number: 02460009. ADR for Janumet. Report numbers: 02333856, 02333864, 02333872.Organization: Health Canada
May 2020
Nothing to report this month
Organization: Destination Canada
Req # A-2019-0017
Access a copy of this briefing note on the Open Government website : Approval to Activate a Rapid Response Process for the Novel Coronavirus 2020-02-06 Ref No: 2020-0018Organization: Canadian Institutes of Health Research
April 2020
Req # A-2020-0004
Briefing note to the President: Approval to Activate a Rapid Response Process for the Novel CoronavirusOrganization: Canadian Institutes of Health Research
April 2020